» Articles » PMID: 25121014

Microbiological Profile and Drug Sensitivity Pattern Among Community Acquired Pneumonia Patients in Tertiary Care Centre in Mangalore, Coastal Karnataka, India

Overview
Specialty General Medicine
Date 2014 Aug 15
PMID 25121014
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Community Acquired Pneumonia (CAP) is the most common respiratory tract infection in day to day practice. The knowledge of organism commonly causative of CAP helps in early empirical treatment initiation.

Aim: To study the microbiological profile of patients with community acquired pneumonia and to study drug sensitivity pattern.

Methods: Hospital based cross sectional study among 100 patients with CAP was conducted in a tertiary care hospital of Southern India. Sputum culture showed that out of 100 patients 39 had an identifiable etiology with 12 patients having evidence of mixed infection.

Result: Micro-organisms isolated in sputum culture were Streptococcus pneumoniae (31%) followed by, Pseudomonas pyogens (15%), Klebsiella pneumoniae (13%). AFB smear was found to be positive in 6 patients. Organisms were found to be sensitive for piperacillin plus tazobactum (41%), aminoglycocides (amikacin-46%, gentamicin-31%), third generation cephalosporins (Cefotaxim-36%, Ceftriaxone-18%) and macrolides (Erythromicin-31%, Azithromycin-18%). Sensitivity to chloramphenicol was observed in 31% sputum culture positive patients. Ciprofloxacin sensitivity was seen among 49%.

Conclusion: Most of the organisms were found to be sensitive to monotherapy with extended spectrum beta lactamases, third generation cephalosporins, fluroquinolones, macrolides.

Citing Articles

Bacterial etiology, antimicrobial resistance and factors associated with community acquired pneumonia among adult hospitalized patients in Southwest Ethiopia.

Mussema A, Beyene G, Gudina E, Alelign D, Mohammed T, Bawore S Iran J Microbiol. 2023; 15(4):492-502.

PMID: 38045716 PMC: 10692968. DOI: 10.18502/ijm.v15i4.13503.


Systematic review and meta-analysis of comorbidities and associated risk factors in Indian patients of community-acquired pneumonia.

Ghia C, Rambhad G SAGE Open Med. 2022; 10:20503121221095485.

PMID: 35509959 PMC: 9058354. DOI: 10.1177/20503121221095485.


Bacterial profile, antimicrobial susceptibility patterns, and associated factors of community-acquired pneumonia among adult patients in Gondar, Northwest Ethiopia: A cross-sectional study.

Assefa M, Tigabu A, Belachew T, Tessema B PLoS One. 2022; 17(2):e0262956.

PMID: 35104293 PMC: 8806065. DOI: 10.1371/journal.pone.0262956.


High proportion of drug-resistant isolates in adult community-acquired pneumonia from Northeast India: A hospital-based study.

Kalita D, Sarma R, Sharma K, Deka S Lung India. 2021; 38(5):460-465.

PMID: 34472525 PMC: 8509170. DOI: 10.4103/lungindia.lungindia_978_20.


Community-acquired bacterial pneumonia in adults: An update.

Eshwara V, Mukhopadhyay C, Rello J Indian J Med Res. 2020; 151(4):287-302.

PMID: 32461392 PMC: 7371062. DOI: 10.4103/ijmr.IJMR_1678_19.


References
1.
Riquelme O R, Riquelme O M, Rioseco Z M, Gomez M V, Gil D R, Torres M A . [Etiology and prognostics factors of community-acquired pneumonia among adults patients admitted to a regional hospital in Chile]. Rev Med Chil. 2006; 134(5):597-605. DOI: 10.4067/s0034-98872006000500008. View

2.
Al-Ali M, Batchoun R, Al-Nour T . Etiology of community-acquired pneumonia in hospitalized patients in Jordan. Saudi Med J. 2006; 27(6):813-6. View

3.
Mandell L, Wunderink R, Anzueto A, Bartlett J, Campbell G, Dean N . Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44 Suppl 2:S27-72. PMC: 7107997. DOI: 10.1086/511159. View

4.
Niederman M . Review of treatment guidelines for community-acquired pneumonia. Am J Med. 2004; 117 Suppl 3A:51S-57S. DOI: 10.1016/j.amjmed.2004.07.008. View

5.
Gupta D, Agarwal R, Aggarwal A, Singh N, Mishra N, Khilnani G . Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. Lung India. 2012; 29(Suppl 2):S27-62. PMC: 3458782. DOI: 10.4103/0970-2113.99248. View